Results 91 to 100 of about 3,560 (171)

Clinical and laboratory aspects of patients diagnosed with various inherited platelet disorders

Research and Practice in Thrombosis and Haemostasis
Background: Inherited platelet disorders (IPDs) are characterized by thrombocytopenia, platelet dysfunction, or both, leading to recurrent bleeding and diagnostic challenges.
Veysel Gök, Alper Ozcan, Fatma Türkan Mutlu, Ebru Yılmaz, Deniz Kocak Göl, Mustafa Ozay, Baver Demir, Hüseyin Taskiran, Hasan Bas, Mehmet Burak Mutlu, Muhammet Ensar Dogan, Atil Bisgin, Ido Somekh, Meino Rohlfs, Munis Dundar, Yusuf Ozkul, Christoph Klein, Musa Karakukcu, Ekrem Unal   +18 more
doaj   +1 more source

#100. Two True and Unrelated: Inpatient Evaluation for Severe Thrombocytopenia

Graduate Medical Education Research Journal
Mentor: Alex Nester Program: Internal Medicine & Pediatrics Type: Case Report Background: Understanding the etiology of thrombocytopenia in hospitalized patients is essential to effective management.
Audrey Lane, Alex Nester
doaj   +1 more source

Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. [PDF]

Oncologist, 2023
Rainone M, Kasparian S, Nguyen T, Talwar N, Yuan Y, Mei M, Mortimer JE, Waisman JR, Patel N, Pullarkat V.   +9 more
europepmc   +1 more source

Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis. [PDF]

BMC Pharmacol Toxicol, 2023
Chen W, Liu Y, Li L, Zeng X.
europepmc   +1 more source

Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. [PDF]

Expert Rev Hematol, 2023
Song AB, Al-Samkari H.
europepmc   +1 more source

Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently. [PDF]

Front Cardiovasc Med, 2023
Yassin MA, Al-Rasheed M, Al-Khaboori M, Marashi M, Osman H, Wali Y, Al Kindi S, Alsayegh F, Provan D.   +8 more
europepmc   +1 more source

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists. [PDF]

Blood Adv, 2023
Drillet G, Lhomme F, De Guibert S, Manson G, Houot R.   +4 more
europepmc   +1 more source

Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis. [PDF]

EJHaem
Ashrafi E, Young L, Fox LC, Ting SB, Wood EM, McQuilten ZK.   +5 more
europepmc   +1 more source

Acquired Amegakaryocytic Thrombocytopenia With Evolution Toward Aplastic Anemia Treated With Thrombopoietin Receptor Agonists: A Case Report. [PDF]

Case Rep Med
Jabbari-Zadeh F, Basharat MM, Chin-Yee B, Phua CW, Lam S, Xenocostas A, To E, Hsia CC.   +7 more
europepmc   +1 more source

Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem. [PDF]

Hematology Am Soc Hematol Educ Program, 2022
Al-Samkari H.
europepmc   +1 more source